COVID-19: An unprecedented challenge and an opportunity for change

Adv Drug Deliv Rev. 2021 Apr:171:48-49. doi: 10.1016/j.addr.2021.01.020. Epub 2021 Jan 29.

¹ Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, USA; Department of Chemical and Biomolecular Engineering, The Henry Samueli School of Engineering, University of California, Irvine, USA; Department of Biomedical Engineering, The Henry Samueli School of Engineering, University of California, Irvine, USA; Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, USA. Electronic address: kwonyj@uci.edu.
² Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, USA; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, USA.

No abstract available

Publication types